Vaisali Chandrasekar
Papers
2
Total Citations
208
H-Index
2
About
Vaisali Chandrasekar is a pioneering researcher at the intersection of nanotechnology, artificial intelligence, and biomedical engineering, with a primary focus on overcoming the formidable blood-brain barrier (BBB) for therapeutic delivery. Her landmark 2021 work, cited over 146 times, explores how nanorobotics and AI can revolutionize the design, controlled maneuvering, and targeting of the BBB—a critical challenge in treating brain cancer and neurological diseases. This research offers a transformative approach to maintaining homeostatic function while delivering theranostics directly to affected neural tissues. Chandrasekar has also made significant contributions to inhalation toxicology, as evidenced by her highly cited 2021 study on lung-on-chip technologies. With 62 citations, this work advances in vitro air-liquid interface models to assess the adverse effects of cigarette smoke, e-cigarette vapor, and environmental particulate matter on lung tissue. Her innovative use of microfluidic organ-on-a-chip platforms provides a more physiologically relevant alternative to traditional animal models, offering unprecedented insights into respiratory health. Chandrasekar’s interdisciplinary work bridges engineering and medicine, positioning her as a leading voice in targeted drug delivery and toxicological risk assessment.
Research Focus
Key Achievements
Top Papers
- 1
- 2